SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a modern pharmacy benefits manager (PBM), was recognized by Modern Healthcare as one of the Best in Business of 2025 – forSAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a modern pharmacy benefits manager (PBM), was recognized by Modern Healthcare as one of the Best in Business of 2025 – for

SmithRx Awarded Modern Healthcare’s Best in Business for Second Consecutive Year

3 min read

SAN FRANCISCO–(BUSINESS WIRE)–SmithRx, a modern pharmacy benefits manager (PBM), was recognized by Modern Healthcare as one of the Best in Business of 2025 – for the second consecutive year. The Modern Healthcare Best in Business award recognizes companies that stand out for excellence in growth, employee engagement, customer satisfaction, and transformative solutions that advance patient care and healthcare delivery. Building on last year’s achievement, SmithRx once again distinguished itself among an impressive field of nominees.

“We are honored to be recognized as a Modern Healthcare Best in Business award recipient for the second year running,” said Jake Frenz, CEO and founder of SmithRx. “This achievement reflects the tireless dedication of our team and their dogged pursuit of a more transparent, more accountable pharmacy benefits system. We are grateful for the continued support of our clients and community as we push the boundaries of what’s possible in pharmacy benefits.”

Since its founding in 2016, SmithRx has focused on challenging legacy pharmacy benefits models and driving innovation, all in service of building a new pharmacy benefits system that works for employers and employees alike. SmithRx’s industry-first platform identifies, secures, and onboards the lowest cost drugs for members, leveraging innovative technology, powerful cost-savings programs, and extensive partnerships within the pharmacy benefits industry. To date, SmithRx has partnered with over 5,000 employer clients to achieve more than $300M in savings for clients, reducing their pharmacy benefit costs by an average of 20%.

The Modern Healthcare Best in Business award winners were selected by an independent panel of industry judges based on criteria that include innovation, business performance, strategic planning, and contributions to the field of healthcare.

“We are proud to honor this year’s recipients of Modern Healthcare’s Best in Business Award,” said Dan Peres, President of Modern Healthcare. “These organizations demonstrate the progress, creativity and excellence that help move healthcare forward. Their innovative approaches and measurable impact are redefining what’s possible in care delivery and operations. Congratulations to this year’s honorees for their exceptional achievements and lasting contributions.”

About SmithRx

SmithRx is a modern PBM dedicated to reducing the cost and complexity of pharmacy benefits. The company empowers organizations of all sizes to take control of their pharmacy spend with a radically transparent, universal pass-through model, innovative cost-saving programs, and intuitive technology. Unlike legacy PBMs, SmithRx eliminates hidden fees, passes through 100% of rebates and discounts, and provides real-time prescription pricing and detailed savings reports. This gives clients the insights they need to make informed decisions and achieve meaningful savings for both their business and their employees. Experience the difference transparency, trust, and fairness can make in building a more equitable healthcare system. Learn more at www.smithrx.com.

About Modern Healthcare

Modern Healthcare is the most trusted business news and information brand in the healthcare industry. Modern Healthcare empowers healthcare leaders and influencers to make timely and informed business decisions. To learn more or subscribe, go to www.modernhealthcare.com/subscriptions.

Contacts

Claire Schillings

[email protected]

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor’s Strategy follows Metaplanet, adding 6,269 BTC worth $729 million

Michael Saylor’s Strategy follows Metaplanet, adding 6,269 BTC worth $729 million

The post Michael Saylor’s Strategy follows Metaplanet, adding 6,269 BTC worth $729 million appeared on BitcoinEthereumNews.com. The two giant BTC holders, Strategy and Metaplanet, have stirred the waters despite the FUD in the Bitcoin market by acquiring a total of 6,269 Bitcoins. According to reports, Strategy has acquired 850 BTC while Metaplanet has acquired a bumper 5,419 tokens. Michael Saylor’s Strategy, the world’s largest corporate Bitcoin holder, purchased BTC worth $99.7 million at $117,344 per Bitcoin. This has brought its total Bitcoin holdings to 639,835 BTC, acquired for about $47.3 billion at $73,971 per Bitcoin. JUST IN: Strategy buys 850 BTC for $99.7M at $117,344 per BTC. Now holds 639,835 $BTCTotal spent: $47.33B Avg cost: $73,971 per BTCYTD BTC yield: 26.0% https://t.co/7iv2difHzR pic.twitter.com/O8WfDpJDxQ — Cryptopolitan (@CPOfficialtx) September 22, 2025 On the other hand, as reported by Cryptopolitan, Metaplanet purchased BTC worth $632.53 million at an average price of roughly $116,724 per Bitcoin. This has brought its total BTC holdings to 25,555 BTC, which was acquired for approximately $2.7 billion and purchased at an average price of $106,065 per BTC. Strategy slows down BTC purchase while Metaplanet adds speed The US company’s most recent Bitcoin purchase is in line with a recent trend of small purchases, showing a slowdown compared to the big purchases seen earlier this year. Strategy bought 3330 Bitcoin in September, which is a big drop from the 7,714 BTC it bought in August and a 75% drop from the 31,466 BTC it bought in July. In line with Bitcoin, Strategy’s stock has dropped about 2% in the last 30 days. Starting in 2020, the company put most of its money into Bitcoin. It used a mix of debt and stock to buy huge amounts of BTC, which turned the business intelligence software company into a Bitcoin giant. Still, the stock has gone up 2,200% since it started buying BTC. On the other hand,…
Share
BitcoinEthereumNews2025/09/22 22:54
Payward Revenue Hits $2.2 Billion as Kraken Exchange Reports Strong 2025 Growth

Payward Revenue Hits $2.2 Billion as Kraken Exchange Reports Strong 2025 Growth

TLDR Payward, Kraken’s parent company, earned $2.2 billion in 2025, a 33% increase from 2024’s $1.6 billion Trading revenue and asset-based services each contributed
Share
Blockonomi2026/02/04 20:11
Super Micro Computer (SMCI) Stock: Revenue Soars Past $12B on AI Server Boom

Super Micro Computer (SMCI) Stock: Revenue Soars Past $12B on AI Server Boom

TLDR Revenue hit $12.7 billion, crushing $10.42 billion estimate and up 123.4% year-over-year EPS of $0.69 beat consensus $0.49 by 40.8% in fiscal Q2 Q3 guidance
Share
Blockonomi2026/02/04 20:36